Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricardo Dent

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Cardiovascular Drugs and Therapy|July 16, 2017
Primary Care Physician Perspectives on Barriers to Statin TreatmentRikki M Tanner, Monika M Safford, Keri L Monda, et al.
Cardiovascular Drugs and Therapy|May 4, 2017
Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further CountriesRobert S Rosenson, Shravanthi R Gandra, Jan McKendrick, et al.
Circulation|March 3, 2017
Pooled Safety Analysis of Evolocumab in Over 6000 Patients From Double-Blind and Open-Label Extension StudiesPeter P Toth, Olivier Descamps, Jacques Genest, et al.
The American Journal of Cardiology|July 31, 2018
Willingness to be Reinitiated on a Statin (from the REasons for Geographic and Racial Differences in Stroke Study)Matthew T Mefford, Gabriel S Tajeu, Rikki M Tanner, et al.
Journal of the American College of Cardiology|March 18, 2017
Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial InfarctionMaria-Corina Serban, Lisandro D Colantonio, Angelika D Manthripragada, et al.
Journal of the American College of Cardiology|April 4, 2014
Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumabErik Stroes, David Colquhoun, David Sullivan, et al.
Journal of the American Heart Association|May 10, 2018
Healthcare Utilization and Statin Re-Initiation Among Medicare Beneficiaries With a History of Myocardial InfarctionJohn N Booth, Lisandro D Colantonio, Robert S Rosenson, et al.
Circulation. Cardiovascular Quality and Outcomes|October 13, 2017
Statin Discontinuation, Reinitiation, and Persistence Patterns Among Medicare Beneficiaries After Myocardial Infarction: A Cohort StudyJohn N Booth, Lisandro D Colantonio, Ligong Chen, et al.
The Journal of Bone and Joint Surgery. American Volume|December 17, 2025
Bezeotermin Alfa (rhBMP-6) Administration in Lumbar Interbody Fusion Surgery Using a Posterior Approach: A Randomized, Double-Blinded, Placebo-Controlled Phase-2 StudyWeishi Li, Xiaoji Luo, Xiaozhong Zhou, et al.
Journal of the American Heart Association|October 4, 2017
Systematic Review and Network Meta-Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in HyperlipidemiaPeter P Toth, Gillian Worthy, Shravanthi R Gandra, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Cardiovascular Drugs and Therapy|July 16, 2017
Primary Care Physician Perspectives on Barriers to Statin TreatmentRikki M Tanner, Monika M Safford, Keri L Monda, et al.
Cardiovascular Drugs and Therapy|May 4, 2017
Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further CountriesRobert S Rosenson, Shravanthi R Gandra, Jan McKendrick, et al.
Circulation|March 3, 2017
Pooled Safety Analysis of Evolocumab in Over 6000 Patients From Double-Blind and Open-Label Extension StudiesPeter P Toth, Olivier Descamps, Jacques Genest, et al.
The American Journal of Cardiology|July 31, 2018
Willingness to be Reinitiated on a Statin (from the REasons for Geographic and Racial Differences in Stroke Study)Matthew T Mefford, Gabriel S Tajeu, Rikki M Tanner, et al.
Journal of the American College of Cardiology|March 18, 2017
Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial InfarctionMaria-Corina Serban, Lisandro D Colantonio, Angelika D Manthripragada, et al.
Journal of the American College of Cardiology|April 4, 2014
Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumabErik Stroes, David Colquhoun, David Sullivan, et al.
Journal of the American Heart Association|May 10, 2018
Healthcare Utilization and Statin Re-Initiation Among Medicare Beneficiaries With a History of Myocardial InfarctionJohn N Booth, Lisandro D Colantonio, Robert S Rosenson, et al.
Circulation. Cardiovascular Quality and Outcomes|October 13, 2017
Statin Discontinuation, Reinitiation, and Persistence Patterns Among Medicare Beneficiaries After Myocardial Infarction: A Cohort StudyJohn N Booth, Lisandro D Colantonio, Ligong Chen, et al.
The Journal of Bone and Joint Surgery. American Volume|December 17, 2025
Bezeotermin Alfa (rhBMP-6) Administration in Lumbar Interbody Fusion Surgery Using a Posterior Approach: A Randomized, Double-Blinded, Placebo-Controlled Phase-2 StudyWeishi Li, Xiaoji Luo, Xiaozhong Zhou, et al.
Journal of the American Heart Association|October 4, 2017
Systematic Review and Network Meta-Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in HyperlipidemiaPeter P Toth, Gillian Worthy, Shravanthi R Gandra, et al.
Pageof 4